Immunomodulating effects of T-44 in comparison to HWA 486.
Schmidt
K
K
Martin-Luther-Universität Halle-Wittenberg, Sektion Pharmazie.
Bekemeier
H
H
Giessler
J
J
Pilopp
H
H
D015057:1-Naphthylamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000627:therapeutic use; D003524:Cyclosporins / Q000494:pharmacology / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D005260:Female; D006087:Graft vs Host Reaction / Q000187:drug effects; D006968:Hypersensitivity, Delayed / Q000276:immunology / Q000517:prevention & control; D007555:Isoxazoles / Q000494:pharmacology* / Q000627:therapeutic use; D000077339:Leflunomide; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D010853:Picryl Chloride
D000276:Adjuvants, Immunologic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003524:Cyclosporins; D007555:Isoxazoles; C069437:1-benzoyl-2-(naphth-1-ylamino)ethene; D015057:1-Naphthylamine; D000077339:Leflunomide; D010853:Picryl Chloride